APO Research
Talk to an analyst

APO RESEARCH · REPORT

Heparin

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Selected research

Market Outlook & Growth Opportunities

Global Heparin Market Outlook and Growth Opportunities 2026

9 January 2026195 pages

Choose your research edition.

Industry ResearchHeparin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Heparin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Heparin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Heparin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Global Heparin key players include Hepalink, Bioibérica, Pfizer, King-friend Biochemical Pharmaceutical, Jiulong Biochemicals, etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 40%, followed by USA, with a share about 35 percent. In terms of product, Heparin Sodium Raw Material Drug is the largest segment, with a share about 96%. And in terms of application, the largest application is Low Molecular Weight Heparin Preparation, followed by Standard Heparin Preparation.

This report provides an overview of the global Heparin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Heparin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Heparin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Heparin market size, projected growth trends, production technologies, key applications, and end-use industries.

Heparin Segment by Company

Hepalink

Changshan Pharm

Qianhong Bio-pharma

Opocrin

Pfizer

Aspen Oss

King-friend Biochemical Pharmaceutical

Bioibérica

Dongcheng Biochemicals

Jiulong Biochemicals

Tiandong

Xinbai

Yino Pharma

Deebio

Heparin Segment by Type

Heparin Sodium Raw Material Drug

Heparin Calcium Raw Material Drug

Heparin Segment by Application

Low Molecular Weight Heparin Preparation

Standard Heparin Preparation

Heparin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Heparin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Heparin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Heparin significant trends, drivers, influence factors in global and regions.

6. To analyze Heparin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Heparin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Heparin industry.

Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Heparin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Heparin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Heparin Industry Trends Table 2. Heparin Industry Drivers Table 3. Heparin Industry Opportunities and Challenges Table 4. Heparin Industry Restraints Table 5. Global Heparin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Heparin Revenue Share by Company (2021-2026) Table 7. Global Heparin Sales Volume by Company (B Units) & (2021-2026) Table 8. Global Heparin Sales Volume Share by Company (2021-2026) Table 9. Global Heparin Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Heparin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Heparin Key Company Manufacturing Base & Headquarters Table 12. Global Heparin Company, Product Type & Application Table 13. Global Heparin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Heparin Sodium Raw Material Drug Table 18. Significant Companies of Heparin Calcium Raw Material Drug Table 19. Global Heparin Sales Volume by Type 2021 VS 2025 VS 2032 (B Units) Table 20. Global Heparin Sales Volume by Type (2021-2026) & (B Units) Table 21. Global Heparin Sales Volume by Type (2027-2032) & (B Units) Table 22. Global Heparin Sales Volume Share by Type (2021-2026) Table 23. Global Heparin Sales Volume Share by Type (2027-2032) Table 24. Global Heparin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Heparin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Heparin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Heparin Sales Value Share by Type (2021-2026) Table 28. Global Heparin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Low Molecular Weight Heparin Preparation Table 30. Significant Companies of Standard Heparin Preparation Table 31. Global Heparin Sales Volume by Application 2021 VS 2025 VS 2032 (B Units) Table 32. Global Heparin Sales Volume by Application (2021-2026) & (B Units) Table 33. Global Heparin Sales Volume by Application (2027-2032) & (B Units) Table 34. Global Heparin Sales Volume Share by Application (2021-2026) Table 35. Global Heparin Sales Volume Share by Application (2027-2032) Table 36. Global Heparin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Heparin Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Heparin Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Heparin Sales Value Share by Application (2021-2026) Table 40. Global Heparin Sales Value Share by Application (2027-2032) Table 41. Global Heparin Sales by Region: 2021 VS 2025 VS 2032 (B Units) Table 42. Global Heparin Sales by Region (2021-2026) & (B Units) Table 43. Global Heparin Sales Market Share by Region (2021-2026) Table 44. Global Heparin Sales by Region (2027-2032) & (B Units) Table 45. Global Heparin Sales Market Share by Region (2027-2032) Table 46. Global Heparin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Heparin Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Heparin Sales Value Share by Region (2021-2026) Table 49. Global Heparin Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Heparin Sales Value Share by Region (2027-2032) Table 51. Global Heparin Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Heparin Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Heparin Sales by Country: 2021 VS 2025 VS 2032 (B Units) Table 54. Global Heparin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Heparin Sales by Country (2021-2026) & (B Units) Table 56. Global Heparin Sales Market Share by Country (2021-2026) Table 57. Global Heparin Sales by Country (2027-2032) & (B Units) Table 58. Global Heparin Sales Market Share by Country (2027-2032) Table 59. Global Heparin Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Heparin Sales Value Market Share by Country (2021-2026) Table 61. Global Heparin Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Heparin Sales Value Market Share by Country (2027-2032) Table 63. Hepalink Company Information Table 64. Hepalink Business Overview Table 65. Hepalink Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Hepalink Heparin Product Portfolio Table 67. Hepalink Recent Development Table 68. Changshan Pharm Company Information Table 69. Changshan Pharm Business Overview Table 70. Changshan Pharm Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Changshan Pharm Heparin Product Portfolio Table 72. Changshan Pharm Recent Development Table 73. Qianhong Bio-pharma Company Information Table 74. Qianhong Bio-pharma Business Overview Table 75. Qianhong Bio-pharma Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Qianhong Bio-pharma Heparin Product Portfolio Table 77. Qianhong Bio-pharma Recent Development Table 78. Opocrin Company Information Table 79. Opocrin Business Overview Table 80. Opocrin Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Opocrin Heparin Product Portfolio Table 82. Opocrin Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Heparin Product Portfolio Table 87. Pfizer Recent Development Table 88. Aspen Oss Company Information Table 89. Aspen Oss Business Overview Table 90. Aspen Oss Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Aspen Oss Heparin Product Portfolio Table 92. Aspen Oss Recent Development Table 93. King-friend Biochemical Pharmaceutical Company Information Table 94. King-friend Biochemical Pharmaceutical Business Overview Table 95. King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. King-friend Biochemical Pharmaceutical Heparin Product Portfolio Table 97. King-friend Biochemical Pharmaceutical Recent Development Table 98. Bioibérica Company Information Table 99. Bioibérica Business Overview Table 100. Bioibérica Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Bioibérica Heparin Product Portfolio Table 102. Bioibérica Recent Development Table 103. Dongcheng Biochemicals Company Information Table 104. Dongcheng Biochemicals Business Overview Table 105. Dongcheng Biochemicals Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Dongcheng Biochemicals Heparin Product Portfolio Table 107. Dongcheng Biochemicals Recent Development Table 108. Jiulong Biochemicals Company Information Table 109. Jiulong Biochemicals Business Overview Table 110. Jiulong Biochemicals Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Jiulong Biochemicals Heparin Product Portfolio Table 112. Jiulong Biochemicals Recent Development Table 113. Tiandong Company Information Table 114. Tiandong Business Overview Table 115. Tiandong Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Tiandong Heparin Product Portfolio Table 117. Tiandong Recent Development Table 118. Xinbai Company Information Table 119. Xinbai Business Overview Table 120. Xinbai Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Xinbai Heparin Product Portfolio Table 122. Xinbai Recent Development Table 123. Yino Pharma Company Information Table 124. Yino Pharma Business Overview Table 125. Yino Pharma Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Yino Pharma Heparin Product Portfolio Table 127. Yino Pharma Recent Development Table 128. Deebio Company Information Table 129. Deebio Business Overview Table 130. Deebio Heparin Sales (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Deebio Heparin Product Portfolio Table 132. Deebio Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Heparin Distributors List Table 136. Heparin Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Heparin Product Image Figure 2. Global Heparin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Heparin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Heparin Sales (2021-2032) & (B Units) Figure 5. Global Heparin Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Heparin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Heparin Sodium Raw Material Drug Image Figure 10. Heparin Calcium Raw Material Drug Image Figure 11. Global Heparin Sales Volume by Type (2021 VS 2025 VS 2032) & (B Units) Figure 12. Global Heparin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Heparin Sales Volume Share by Type (2021-2032) Figure 14. Global Heparin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Heparin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Heparin Sales Value Share by Type (2021-2032) Figure 17. Low Molecular Weight Heparin Preparation Image Figure 18. Standard Heparin Preparation Image Figure 19. Global Heparin Sales Volume by Application (2021 VS 2025 VS 2032) & (B Units) Figure 20. Global Heparin Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Heparin Sales Volume Share by Application (2021-2032) Figure 22. Global Heparin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Heparin Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Heparin Sales Value Share by Application (2021-2032) Figure 25. Global Heparin Sales by Region: 2021 VS 2025 VS 2032 (B Units) Figure 26. Global Heparin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Heparin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Heparin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Heparin Sales Value (2021-2032) & (US$ Million) Figure 30. North America Heparin Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Heparin Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Heparin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Heparin Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Heparin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Heparin Sales Value (2021-2032) & (US$ Million) Figure 36. South America Heparin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Heparin Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Heparin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Heparin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Heparin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Heparin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Heparin Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Heparin Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Heparin Sodium Raw Material Drug
  • Heparin Calcium Raw Material Drug
Applications
  • Low Molecular Weight Heparin Preparation
  • Standard Heparin Preparation
Companies covered
  • Hepalink
  • Changshan Pharm
  • Qianhong Bio-pharma
  • Opocrin
  • Pfizer
  • Aspen Oss
  • King-friend Biochemical Pharmaceutical
  • Bioibérica
  • Dongcheng Biochemicals
  • Jiulong Biochemicals
  • Tiandong
  • Xinbai
  • Yino Pharma
  • Deebio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Heparin Sales Value (2021-2032)
  4. 1.2.2 Global Heparin Sales Volume (2021-2032)
  5. 1.2.3 Global Heparin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Heparin Market Dynamics
  1. 2.1 Heparin Industry Trends
  2. 2.2 Heparin Industry Drivers
  3. 2.3 Heparin Industry Opportunities and Challenges
  4. 2.4 Heparin Industry Restraints
3 Heparin Market by Company
  1. 3.1 Global Heparin Company Revenue Ranking in 2025
  2. 3.2 Global Heparin Revenue by Company (2021-2026)
  3. 3.3 Global Heparin Sales Volume by Company (2021-2026)
  4. 3.4 Global Heparin Average Price by Company (2021-2026)
  5. 3.5 Global Heparin Company Ranking (2024-2026)
  6. 3.6 Global Heparin Company Manufacturing Base and Headquarters
  7. 3.7 Global Heparin Company Product Type and Application
  8. 3.8 Global Heparin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Heparin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Heparin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Heparin Market by Type
  1. 4.1 Heparin Type Introduction
  2. 4.1.1 Heparin Sodium Raw Material Drug
  3. 4.1.2 Heparin Calcium Raw Material Drug
  4. 4.2 Global Heparin Sales Volume by Type
  5. 4.2.1 Global Heparin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Heparin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Heparin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Heparin Sales Value by Type
  9. 4.3.1 Global Heparin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Heparin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Heparin Sales Value Share by Type (2021-2032)
5 Heparin Market by Application
  1. 5.1 Heparin Application Introduction
  2. 5.1.1 Low Molecular Weight Heparin Preparation
  3. 5.1.2 Standard Heparin Preparation
  4. 5.2 Global Heparin Sales Volume by Application
  5. 5.2.1 Global Heparin Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Heparin Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Heparin Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Heparin Sales Value by Application
  9. 5.3.1 Global Heparin Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Heparin Sales Value by Application (2021-2032)
  11. 5.3.3 Global Heparin Sales Value Share by Application (2021-2032)
6 Heparin Regional Sales and Value Analysis
  1. 6.1 Global Heparin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Heparin Sales by Region (2021-2032)
  3. 6.2.1 Global Heparin Sales by Region: 2021-2026
  4. 6.2.2 Global Heparin Sales by Region (2027-2032)
  5. 6.3 Global Heparin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Heparin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Heparin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Heparin Sales Value by Region (2027-2032)
  9. 6.5 Global Heparin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Heparin Sales Value (2021-2032)
  12. 6.6.2 North America Heparin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Heparin Sales Value (2021-2032)
  15. 6.7.2 Europe Heparin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Heparin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Heparin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Heparin Sales Value (2021-2032)
  21. 6.9.2 South America Heparin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Heparin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Heparin Sales Value Share by Country, 2025 VS 2032
7 Heparin Country-level Sales and Value Analysis
  1. 7.1 Global Heparin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Heparin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Heparin Sales by Country (2021-2032)
  4. 7.3.1 Global Heparin Sales by Country (2021-2026)
  5. 7.3.2 Global Heparin Sales by Country (2027-2032)
  6. 7.4 Global Heparin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Heparin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Heparin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Heparin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Heparin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Heparin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Heparin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Heparin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Heparin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Heparin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Heparin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Heparin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Heparin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Heparin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Heparin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Heparin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Heparin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Heparin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Heparin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Heparin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Heparin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Heparin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Heparin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Heparin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Heparin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Heparin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Heparin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Heparin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Heparin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Heparin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Heparin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Heparin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Heparin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Heparin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Heparin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Heparin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Heparin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Heparin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Heparin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Heparin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Heparin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Heparin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Heparin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Heparin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Heparin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Heparin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Heparin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Heparin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Heparin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Heparin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Heparin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Heparin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Heparin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Heparin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Heparin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Heparin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Heparin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Heparin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Heparin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Heparin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Heparin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Heparin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Heparin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Heparin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Heparin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Heparin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Heparin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Heparin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Heparin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Heparin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Heparin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Heparin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Heparin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Heparin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Heparin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Heparin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Heparin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Heparin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Heparin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Heparin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Heparin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Heparin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Heparin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Heparin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Heparin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Heparin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Heparin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hepalink
  2. 8.1.1 Hepalink Company Information
  3. 8.1.2 Hepalink Business Overview
  4. 8.1.3 Hepalink Heparin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hepalink Heparin Product Portfolio
  6. 8.1.5 Hepalink Recent Developments
  7. 8.2 Changshan Pharm
  8. 8.2.1 Changshan Pharm Company Information
  9. 8.2.2 Changshan Pharm Business Overview
  10. 8.2.3 Changshan Pharm Heparin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Changshan Pharm Heparin Product Portfolio
  12. 8.2.5 Changshan Pharm Recent Developments
  13. 8.3 Qianhong Bio-pharma
  14. 8.3.1 Qianhong Bio-pharma Company Information
  15. 8.3.2 Qianhong Bio-pharma Business Overview
  16. 8.3.3 Qianhong Bio-pharma Heparin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qianhong Bio-pharma Heparin Product Portfolio
  18. 8.3.5 Qianhong Bio-pharma Recent Developments
  19. 8.4 Opocrin
  20. 8.4.1 Opocrin Company Information
  21. 8.4.2 Opocrin Business Overview
  22. 8.4.3 Opocrin Heparin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Opocrin Heparin Product Portfolio
  24. 8.4.5 Opocrin Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Heparin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Heparin Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Aspen Oss
  32. 8.6.1 Aspen Oss Company Information
  33. 8.6.2 Aspen Oss Business Overview
  34. 8.6.3 Aspen Oss Heparin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aspen Oss Heparin Product Portfolio
  36. 8.6.5 Aspen Oss Recent Developments
  37. 8.7 King-friend Biochemical Pharmaceutical
  38. 8.7.1 King-friend Biochemical Pharmaceutical Company Information
  39. 8.7.2 King-friend Biochemical Pharmaceutical Business Overview
  40. 8.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 King-friend Biochemical Pharmaceutical Heparin Product Portfolio
  42. 8.7.5 King-friend Biochemical Pharmaceutical Recent Developments
  43. 8.8 Bioibérica
  44. 8.8.1 Bioibérica Company Information
  45. 8.8.2 Bioibérica Business Overview
  46. 8.8.3 Bioibérica Heparin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bioibérica Heparin Product Portfolio
  48. 8.8.5 Bioibérica Recent Developments
  49. 8.9 Dongcheng Biochemicals
  50. 8.9.1 Dongcheng Biochemicals Company Information
  51. 8.9.2 Dongcheng Biochemicals Business Overview
  52. 8.9.3 Dongcheng Biochemicals Heparin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dongcheng Biochemicals Heparin Product Portfolio
  54. 8.9.5 Dongcheng Biochemicals Recent Developments
  55. 8.10 Jiulong Biochemicals
  56. 8.10.1 Jiulong Biochemicals Company Information
  57. 8.10.2 Jiulong Biochemicals Business Overview
  58. 8.10.3 Jiulong Biochemicals Heparin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jiulong Biochemicals Heparin Product Portfolio
  60. 8.10.5 Jiulong Biochemicals Recent Developments
  61. 8.11 Tiandong
  62. 8.11.1 Tiandong Company Information
  63. 8.11.2 Tiandong Business Overview
  64. 8.11.3 Tiandong Heparin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Tiandong Heparin Product Portfolio
  66. 8.11.5 Tiandong Recent Developments
  67. 8.12 Xinbai
  68. 8.12.1 Xinbai Company Information
  69. 8.12.2 Xinbai Business Overview
  70. 8.12.3 Xinbai Heparin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Xinbai Heparin Product Portfolio
  72. 8.12.5 Xinbai Recent Developments
  73. 8.13 Yino Pharma
  74. 8.13.1 Yino Pharma Company Information
  75. 8.13.2 Yino Pharma Business Overview
  76. 8.13.3 Yino Pharma Heparin Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Yino Pharma Heparin Product Portfolio
  78. 8.13.5 Yino Pharma Recent Developments
  79. 8.14 Deebio
  80. 8.14.1 Deebio Company Information
  81. 8.14.2 Deebio Business Overview
  82. 8.14.3 Deebio Heparin Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Deebio Heparin Product Portfolio
  84. 8.14.5 Deebio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Heparin Value Chain Analysis
  2. 9.1.1 Heparin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Heparin Sales Mode & Process
  6. 9.2 Heparin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Heparin Distributors
  9. 9.2.3 Heparin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst